101.90
101.90 (0%)
As of Apr 25, 2025
BOSTON SCIENTIFIC CORP [BSX]
Source:
Company Overview
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.
| Country | United States |
| Headquarters | marlborough, massachusetts |
| Phone Number | (508) 683-4000 |
| Industry | manufacturing |
| CEO | Michael F. Mahoney |
| Website | www.bostonscientific.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $4,209 |
| Operating Profit | $733 |
| Net Income | $468 |
| Net Cash | $1,594 |
Profit Ratios
| Gross Margin | $2,897 |
| Operating Margin | 17.4 |
| Profit as % of Revenues | 619% |
| Profit as % of Assets | 2.2% |
| Profit as % of Stockholder Equity | 2.2% |
Management Effectiveness
| Return on Equity | 2.2% |
| Return on Assets | 1.2% |
| Turnover Ratio | 19.9% |
| EBITA | $938 |
Balance Sheet and Cash Flow Measures
| Total Assets | $38,078 |
| Total Liabilities | $17,122 |
| Operating Cash Flow | $1,979 |
| Investing Cash Flow | $-1,983 |
| Financing Cash Flow | $1,600 |
